Sign In
Buy PHR
Phreesia Earnings Calls
| Release date | May 27, 2026 |
| EPS estimate | $0.0200 |
| EPS actual | $0.0500 |
| EPS Surprise | 150.00% |
| Revenue estimate | 130.078M |
| Revenue actual | 130.935M |
| Revenue Surprise | 0.659% |
| Release date | Mar 30, 2026 |
| EPS estimate | $0.0657 |
| EPS actual | $0.120 |
| EPS Surprise | 82.62% |
| Revenue estimate | 126.75M |
| Revenue actual | 127.067M |
| Revenue Surprise | 0.250% |
| Release date | Dec 08, 2025 |
| EPS estimate | -$0.0004 |
| EPS actual | $0.100 |
| EPS Surprise | 27,877.78% |
| Revenue estimate | 120.014M |
| Revenue actual | 120.333M |
| Revenue Surprise | 0.266% |
| Release date | Sep 04, 2025 |
| EPS estimate | -$0.0700 |
| EPS actual | $0.0100 |
| EPS Surprise | 114.29% |
| Revenue estimate | 120.166M |
| Revenue actual | 117.255M |
| Revenue Surprise | -2.42% |
Last 4 Quarters for Phreesia
Below you can see how PHR performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Sep 04, 2025 |
| Price on release | $31.21 |
| EPS estimate | -$0.0700 |
| EPS actual | $0.0100 |
| EPS surprise | 114.29% |
| Date | Price |
|---|---|
| Aug 28, 2025 | $32.55 |
| Aug 29, 2025 | $31.66 |
| Sep 02, 2025 | $31.48 |
| Sep 03, 2025 | $30.44 |
| Sep 04, 2025 | $31.21 |
| Sep 05, 2025 | $28.13 |
| Sep 08, 2025 | $26.78 |
| Sep 09, 2025 | $26.55 |
| Sep 10, 2025 | $25.34 |
| 4 days before | -4.12% |
| 4 days after | -18.81% |
| On release day | -9.87% |
| Change in period | -22.15% |
| Release date | Dec 08, 2025 |
| Price on release | $20.12 |
| EPS estimate | -$0.0004 |
| EPS actual | $0.100 |
| EPS surprise | 27,877.78% |
| Date | Price |
|---|---|
| Dec 02, 2025 | $20.15 |
| Dec 03, 2025 | $20.38 |
| Dec 04, 2025 | $20.55 |
| Dec 05, 2025 | $20.29 |
| Dec 08, 2025 | $20.12 |
| Dec 09, 2025 | $15.42 |
| Dec 10, 2025 | $15.80 |
| Dec 11, 2025 | $16.05 |
| Dec 12, 2025 | $16.18 |
| 4 days before | -0.149% |
| 4 days after | -19.61% |
| On release day | -23.36% |
| Change in period | -19.73% |
| Release date | Mar 30, 2026 |
| Price on release | $11.41 |
| EPS estimate | $0.0657 |
| EPS actual | $0.120 |
| EPS surprise | 82.62% |
| Date | Price |
|---|---|
| Mar 24, 2026 | $11.28 |
| Mar 25, 2026 | $11.28 |
| Mar 26, 2026 | $11.65 |
| Mar 27, 2026 | $10.98 |
| Mar 30, 2026 | $11.41 |
| Mar 31, 2026 | $8.38 |
| Apr 01, 2026 | $8.40 |
| Apr 02, 2026 | $8.37 |
| Apr 06, 2026 | $9.15 |
| 4 days before | 1.15% |
| 4 days after | -19.81% |
| On release day | -26.56% |
| Change in period | -18.88% |
| Release date | May 27, 2026 |
| Price on release | $9.13 |
| EPS estimate | $0.0200 |
| EPS actual | $0.0500 |
| EPS surprise | 150.00% |
| Date | Price |
|---|---|
| May 20, 2026 | $8.85 |
| May 21, 2026 | $8.78 |
| May 22, 2026 | $8.92 |
| May 26, 2026 | $8.95 |
| May 27, 2026 | $9.13 |
| May 28, 2026 | $9.45 |
| May 29, 2026 | $9.86 |
| Jun 01, 2026 | $10.66 |
| Jun 02, 2026 | $10.36 |
| 4 days before | 3.16% |
| 4 days after | 13.47% |
| On release day | 3.50% |
| Change in period | 17.06% |
Phreesia Earnings Call Transcript Summary of Q2 2026
Phreesia announced a definitive agreement to acquire AccessOne for $160 million in cash, expanding Phreesia's payments addressable market and expected to add roughly $35 million in annualized revenue and ~$11 million in annualized adjusted EBITDA. The deal is expected to close in Q3 or early Q4 FY2026 and will be financed with a combination of cash on hand and a fully committed bridge loan. Phreesia reported Q2 FY2026 revenue of $117.3 million (up 15% YoY), average healthcare services clients (AHSCs) of 4,467, revenue per AHSC of $26,249 (up 7% YoY), adjusted EBITDA of $22 million (19% margin), and its first-ever GAAP net income of $0.7 million. Cash and equivalents were $98.3 million; operating cash flow was $14.8 million and free cash flow $9.6 million. The company maintained FY2026 revenue guidance of $472–$482 million and raised adjusted EBITDA guidance to $87–$92 million. Management highlighted new AI-driven products (notably Phreesia Voice AI) as rapidly adopted, potential drivers of future network solutions TAM expansion, and reiterated a product-led go-to-market approach where many new offerings are initially provided at no cost to clients.
